These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12466357)

  • 21. Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue.
    Mai K; Andres J; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):419-25. PubMed ID: 17555498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
    Mai K; Kullmann V; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased glucocorticoid activity in men with cardiovascular risk factors.
    Walker BR; Phillips DI; Noon JP; Panarelli M; Andrew R; Edwards HV; Holton DW; Seckl JR; Webb DJ; Watt GC
    Hypertension; 1998 Apr; 31(4):891-5. PubMed ID: 9535410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats.
    Drake AJ; Livingstone DE; Andrew R; Seckl JR; Morton NM; Walker BR
    Endocrinology; 2005 Feb; 146(2):913-9. PubMed ID: 15550507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated measurements of 11β-HSD-1 activity in subcutaneous adipose tissue from lean, abdominally obese, and type 2 diabetes subjects--no change following a mixed meal.
    Sjöstrand M; Jansson PA; Palming J; de Schoolmeester J; Gill D; Rees A; Sjögren L; Persson T; Eriksson JW
    Horm Metab Res; 2010 Oct; 42(11):798-802. PubMed ID: 20514603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary male osteoporosis is associated with enhanced glucocorticoid availability.
    Arampatzis S; Pasch A; Lippuner K; Mohaupt M
    Rheumatology (Oxford); 2013 Nov; 52(11):1983-91. PubMed ID: 23882110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired glucose tolerance and elevated blood pressure in low birth weight, nonobese, young south african adults: early programming of cortisol axis.
    Levitt NS; Lambert EV; Woods D; Hales CN; Andrew R; Seckl JR
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4611-8. PubMed ID: 11134116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the hypothalamic-pituitary-adrenal axis in obesity: cause or consequence?
    Walker BR
    Growth Horm IGF Res; 2001 Jun; 11 Suppl A():S91-5. PubMed ID: 11527096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlations between the hypothalamo-pituitary-adrenal axis and the metabolic syndrome].
    Góth M; Hubina E; Korbonits M
    Orv Hetil; 2005 Jan; 146(2):51-5. PubMed ID: 15724952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortisol metabolism in depressed patients and healthy controls.
    Römer B; Lewicka S; Kopf D; Lederbogen F; Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Deuschle M
    Neuroendocrinology; 2009; 90(3):301-6. PubMed ID: 19713693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 11β-hydroxysteroid dehydrogenase types 1 and 2 activity in subcutaneous adipose tissue in humans: implications in obesity and diabetes.
    Dube S; Norby BJ; Pattan V; Carter RE; Basu A; Basu R
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E70-6. PubMed ID: 25303491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity.
    Müssig K; Remer T; Haupt A; Gallwitz B; Fritsche A; Häring HU; Maser-Gluth C
    Obesity (Silver Spring); 2008 Jun; 16(6):1256-60. PubMed ID: 18421276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 11beta-hydroxysteroid dehydrogenase activity in acromegalic patients with normal or impaired carbohydrate metabolism.
    Mondok A; Varga I; Glaz E; Szucs N; Tóth M; Patocs A; Beko G; Racz K
    Steroids; 2009 Sep; 74(9):725-9. PubMed ID: 19540999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes.
    Andrews RC; Rooyackers O; Walker BR
    J Clin Endocrinol Metab; 2003 Jan; 88(1):285-91. PubMed ID: 12519867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sixty years after Hench--corticosteroids and chronic inflammatory disease.
    Edwards C
    J Clin Endocrinol Metab; 2012 May; 97(5):1443-51. PubMed ID: 22378812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism.
    Draper N; Echwald SM; Lavery GG; Walker EA; Fraser R; Davies E; Sørensen TI; Astrup A; Adamski J; Hewison M; Connell JM; Pedersen O; Stewart PM
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4984-90. PubMed ID: 12414862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortisol metabolism after weight loss: associations with 11 β-HSD type 1 and markers of obesity in women.
    Rask E; Simonyte K; Lönn L; Axelson M
    Clin Endocrinol (Oxf); 2013 May; 78(5):700-5. PubMed ID: 22233384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
    Baudrand R; Domínguez JM; Carvajal CA; Riquelme A; Campino C; Macchiavello S; Bozinovic M; Morales M; Pizarro M; Solis N; Escalona A; Boza C; Arrese M; Fardella CE
    Metabolism; 2011 Dec; 60(12):1775-80. PubMed ID: 21704348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased systemic cortisol metabolism in patients with schizophrenia and bipolar disorder: a mechanism for increased stress vulnerability?
    Steen NE; Methlie P; Lorentzen S; Hope S; Barrett EA; Larsson S; Mork E; Almås B; Løvås K; Agartz I; Melle I; Berg JP; Andreassen OA
    J Clin Psychiatry; 2011 Nov; 72(11):1515-21. PubMed ID: 21367348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study.
    Paulmyer-Lacroix O; Boullu S; Oliver C; Alessi MC; Grino M
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2701-5. PubMed ID: 12050237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.